Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Inventory (2020 - 2025)

Journey Medical's Change in Inventory history spans 6 years, with the latest figure at -$2.2 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 183.01% year-over-year to -$2.2 million, compared with a TTM value of -$4.8 million through Dec 2025, down 213.78%, and an annual FY2025 reading of -$4.8 million, down 213.78% over the prior year.
  • Change in Inventory for Q4 2025 was -$2.2 million at Journey Medical, down from -$1.0 million in the prior quarter.
  • The five-year high for Change in Inventory was $12.0 million in Q2 2021, with the low at -$2.7 million in Q3 2021.
  • Average Change in Inventory over 5 years is $108950.0, with a median of -$852000.0 recorded in 2022.
  • Year-over-year, Change in Inventory crashed 1223.81% in 2023 and then skyrocketed 423.11% in 2024.
  • Tracing DERM's Change in Inventory over 5 years: stood at -$1.8 million in 2021, then skyrocketed by 38.87% to -$1.1 million in 2022, then grew by 23.62% to -$818000.0 in 2023, then skyrocketed by 423.11% to $2.6 million in 2024, then tumbled by 183.01% to -$2.2 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Change in Inventory are -$2.2 million (Q4 2025), -$1.0 million (Q3 2025), and $356000.0 (Q2 2025).